RE:RE:RE:So... The question is, Why the hold down this timeAureus, I tend to agree with you. I believe the share price is low because P. Laurin is trying to hold on to as much as he can (because he really has something) therefore no major partnerships so far. Going it alone means more struggling (additional financing etc.) on the part of Prometic but in the end, wow it is going to be great. I just hope things speed up somewhere re. revenure because revenue is what investors want to hear. I suspect the wound healing injections partnered with Swedish Company will move along quicker than we can imagine and be a cornerstone to moving the share price higher. Best to the longs.